Your browser doesn't support javascript.
loading
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA.
Vella Bonanno, Patricia; Bucsics, Anna; Simoens, Steven; Martin, Antony P; Oortwijn, Wija; Gulbinovic, Jolanta; Rothe, Celia; Timoney, Angela; Ferrario, Alessandra; Gad, Mohamed; Salem, Ahmed; Hoxha, Iris; Sauermann, Robert; Kamusheva, Maria; Dimitrova, Maria; Petrova, Guenka; Laius, Ott; Selke, Gisbert; Kourafalos, Vasilios; Yfantopoulos, John; Magnusson, Einar; Joppi, Roberta; Jakupi, Arianit; Bochenek, Tomasz; Wladysiuk, Magdalene; Furtado, Claudia; Markovic-Pekovic, Vanda; Mardare, Ileana; Meshkov, Dmitry; Fürst, Jurij; Tomek, Dominik; Cortadellas, Merce Obach; Zara, Corrine; Haycox, Alan; Campbell, Stephen; Godman, Brian.
Afiliación
  • Vella Bonanno P; a Strathclyde Institute of Pharmacy and Biomedical Sciences , University of Strathclyde , Glasgow , UK.
  • Bucsics A; b Mechanism of Coordinated Access to Orphan Medicinal Products (MoCA) , Brussels , Belgium.
  • Simoens S; c KU Leuven Department of Pharmaceutical and Pharmacological Sciences , Leuven , Belgium.
  • Martin AP; d Health Economics Centre , University of Liverpool Management School , Liverpool , UK.
  • Oortwijn W; e Department for Health Evidence , Radboud University Medical Center , Nijmegen , The Netherlands.
  • Gulbinovic J; f Department of Pathology, Forensic Medicine and Pharmacology , Institute of Biomedical Sciences, Faculty of Medicine, VilniusUniversity , Vilnius , Lithuania.
  • Rothe C; g Department of Drug Management, Faculty of Health Sciences , Jagiellonian University Medical College , Krakow , Poland.
  • Timoney A; a Strathclyde Institute of Pharmacy and Biomedical Sciences , University of Strathclyde , Glasgow , UK.
  • Ferrario A; h NHS Lothian , Edinburgh , UK.
  • Gad M; i Division of Health Policy and Insurance Research, Department of Population Medicine , Harvard Medical School and Harvard Pilgrim Health Care Institute , Boston , MA , USA.
  • Salem A; j Global Health and Development Group , Imperial College , London , UK.
  • Hoxha I; k IQVIA , Brussels , Belgium.
  • Sauermann R; l Department of Pharmacy, Faculty of Medicine , University of Medicine , Tirana , Albania.
  • Kamusheva M; m Hauptverband der ÖsterreichischenSozialversicherungsträger , Vienna , Austria.
  • Dimitrova M; n Department of Organization and Economics of Pharmacy, Faculty of Pharmacy , Medical University-Sofia , Bulgaria.
  • Petrova G; n Department of Organization and Economics of Pharmacy, Faculty of Pharmacy , Medical University-Sofia , Bulgaria.
  • Laius O; n Department of Organization and Economics of Pharmacy, Faculty of Pharmacy , Medical University-Sofia , Bulgaria.
  • Selke G; o State Agency of Medicines , Tartu , Estonia.
  • Kourafalos V; p Wissenschaftliches Institut der AOK (WidO) , Berlin , Germany.
  • Yfantopoulos J; q EOPYY-National Organization for the Provision of Healthcare Services , Athens , Greece.
  • Magnusson E; r School of Economics and Political Science , University of Athens , Athens , Greece.
  • Joppi R; s Department of Health Services , Ministry of Health , Reykjavík , Iceland.
  • Jakupi A; t Pharmaceutical Drug Department , Azienda Sanitaria Locale of Verona , Verona , Italy.
  • Bochenek T; u UBT - Higher Education Institute , Prishtina , Kosovo.
  • Wladysiuk M; g Department of Drug Management, Faculty of Health Sciences , Jagiellonian University Medical College , Krakow , Poland.
  • Furtado C; v HTA Consulting , Cracow , Poland.
  • Markovic-Pekovic V; w Pharmaceutical Division , INFAMED , Lisbon , Portugal.
  • Mardare I; x Ministry of Health and Social Welfare , Banja Luka , Republic of Srpska, Bosnia and Herzegovina.
  • Meshkov D; y Department of Social Pharmacy , University of Banja Luka, Faculty of Medicine , Banja Luka , Republic of Srpska, Bosnia and Herzegovina.
  • Fürst J; z Faculty of Medicine, Public Health and Management Department , "Carol Davila" University of Medicine and Pharmacy Bucharest , Bucharest , Romania.
  • Tomek D; aa National Research Institution for Public Health , Moscow , Russia.
  • Cortadellas MO; ab Health Insurance Institute , Ljubljana , Slovenia.
  • Zara C; ac Faculty of Medicine, Slovak Medical University , Bratislava , Slovakia .
  • Haycox A; ad Drug Territorial Action Unit , Catalan Health Service , Barcelona , Spain.
  • Campbell S; ad Drug Territorial Action Unit , Catalan Health Service , Barcelona , Spain.
  • Godman B; d Health Economics Centre , University of Liverpool Management School , Liverpool , UK.
Expert Rev Pharmacoecon Outcomes Res ; 19(3): 251-261, 2019 Jun.
Article en En | MEDLINE | ID: mdl-30696372
ABSTRACT

INTRODUCTION:

In January 2018 the European Commission published a Proposal for a Regulation on Health Technology Assessment (HTA) 'Proposal for a Regulation on health technology assessment and amending Directive 2011/24/EU'. A number of stakeholders, including some Member States, welcomed this initiative as it was considered to improve collaboration, reduce duplication and improve efficiency. There were however a number of concerns including its legal basis, the establishment of a single managing authority, the preservation of national jurisdiction over HTA decision-making and the voluntary/mandatory uptake of joint assessments by Member States. Areas covered This paper presents the consolidated views and considerations on the original Proposal as set by the European Commission of a number of policy makers, payers, experts from pricing and reimbursement authorities and academics from across Europe. Expert commentary The Proposal has since been extensively discussed at Council and while good progress has been achieved, there are still divergent positions. The European Parliament gave a number of recommendations for amendments. If the Proposal is approved, it is important that a balanced, improved outcome is achieved for all stakeholders. If not approved, the extensive contribution and progress attained should be sustained and preserved, and the best alternative solutions found.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Formulación de Políticas / Evaluación de la Tecnología Biomédica / Política de Salud Tipo de estudio: Health_technology_assessment Límite: Humans Idioma: En Revista: Expert Rev Pharmacoecon Outcomes Res Asunto de la revista: FARMACOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Formulación de Políticas / Evaluación de la Tecnología Biomédica / Política de Salud Tipo de estudio: Health_technology_assessment Límite: Humans Idioma: En Revista: Expert Rev Pharmacoecon Outcomes Res Asunto de la revista: FARMACOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido